Diabetes

(035) Assessing the utility of claims for haemoglobin A1c performance measures in characterizing glycemic control in older adult Medicare beneficiaries with diabetes.

(036) Association of educational level with clinical presentation and pharmacological treatment in 10,020 individuals with recently diagnosed type 2 diabetes

(037) Association of multimorbidity intervals with the risk of mortality among people living with diabetes: a territory-wide nested case-control study

(038) Cardiovascular Risk of Hormone Replacement Therapy in Menopausal Women with Diabetes: A Systematic Review and Meta-Analysis of Clinical Trials and Observational Studies

(039) Comparative Analysis of Potential Misuse between Tirzepatide and Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs): Insights from FDA Adverse Event Reporting System (FAERS) Data

(040) Comparative Effectiveness of Anti-TNF Therapy and Vedolizumab in Crohn's Disease Patients

(041) Comparative Protective Effect on Alzheimer Disease between GLP1-RA and SGLT2 Inhibitors

(045) Effect of COVID-19 restrictions on insulin consumption in Turkey: Results from Changes in Nationwide Drug Consumption During the Pandemic Study

(046) Effect of SGLT2 Inhibitors on Decreasing the Risk of Depression in Patients with Diabetes: A Nationwide Active-Comparator Cohort Study in Taiwan

(048) Exploring early signals for gliptins and gliflozins: A pharmacovigilance study on recent oral antidiabetic groups in Spain.

(049) Hypoglycaemia Risk and Medication De-intensification in Diabetes Patients: A Cohort Study

(050) Identifying Prediabetes Patients Using Administrative Claims Linked with Lab Data to Assess Progression To Type 2 Diabetes and Treatment Initiation Patterns

(051) Incidence of Diabetic Ketoacidosis in Dapagliflozin Users vs. SGLT2i Non-users with Type 1 Diabetes Mellitus using a Japanese Claims Database

(052) Incretin-Based Drugs and the Incidence of Endometrial Cancer Among Patients with Type 2 Diabetes

(053) Incretin-based drugs and the risk of gallbladder or biliary tract diseases among patients with type 2 diabetes across categories of body mass index: A nationwide cohort study

(055) Insulin Consumption Trends in Greece: A Retrospective Analysis of Diabetes consumption based on EOPPY Dataset (2015-2020)

(056) Investigating ethnic differences in the comparative effectiveness of classes of second-line antidiabetic medications at preventing cardiovascular outcomes.

(057) Methods for Extrapolating Findings from Randomized Clinical Trials using Real-World-Data

(058) Migration Background and HbA1c Checks and Balances: A Large Routine Care Data Study in the Netherlands

(059) Novel Glucose-lowering Drugs and Incident Dementia Among Patients With Type 2 Diabetes and Comorbid Mental Disorders: A Population-based Cohort Study

(060) Predicting Insulin Consumption in Relation to Diabetes: A Pharmacoepidemiological Analysis of the EOPYY Dataset in Greece (2015-2020)

(061) Predictive Model for Sight-Threatening Diabetic Retinopathy in People with Type 2 Diabetes Mellitus

(062) Prevalence of potentially inappropriate medications among newly treated patients with type 2 diabetes in UK primary practice

(063) Psychometric properties of the Treatment Satisfaction with Medicine Questionnaire (SATMED-Q) in Indonesian patients with type 2 diabetes

(065) Relationship between Anti-diabetic Medication Use and Glycaemic Control in an Asian Cohort with Diabetes in Singapore

(068) Risk of New-onset Type 2 Diabetes Mellitus Associated with 5-Alpha Reductase Inhibitors: A Nationwide Population-Based Study

(069) Safety of concomitant use of antidiabetic drugs and oral anticoagulants: a systematic review of observational studies

(070) Semaglutide injection with type 2 diabetes indication – User trends and Off-label Prescribing for Weight Loss from 2018 through 2023 in Denmark

(071) Sex Disparities in Medication Changes After Metformin Initiation are Associated With Small, Clinically Non-Relevant, Sex Differences in HbA1c Levels During Follow-up

(072) Temporal Trends in the Dispensing Patterns of Semaglutide and Dulaglutide in Ireland from 2018-2023

(074) The Prevalence of Depression among Patients with Type 2 Diabetes: An Umbrella Review

(075) The Use of Potentially Interacting Supplement–Drug Pairs in Adults with Type 2 Diabetes: A Large Population-Based Cohort Study in the UK Biobank

(076) Treatment Modification Patterns of Glucose-Lowering Agents in Saudi Arabia: A Retrospective Real-world Data Analysis

(079) Use of new technologies and well-being in adults with type 1 diabetes mellitus

(080) Utilization of sodium-glucose cotransporter 2 inhibitors post-regulatory approval as an adjunctive therapy for type 1 diabetes mellitus: Insight from real-world experience in Japan